Form D · Biotechnology
Aurita Corp
Gainesville, FL · CIK 0001937883
Offering snapshot reported May 24, 2024 · SEC filing
- Reported sold
- $180K Offering amount: $400K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 10, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2024 | Initial | $180,491 | No comparison | 3 | SEC filing |
| Jul 13, 2022 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-514232
Source: Form D, filed May 24, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Blaser | Director |
| Gregory Kis | Director |
| Joe Miletich | Director, Executive, Promoter |
| Wallace Gregory Sawyer | Director, Executive |
| Stephanie Warrington | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
107 Sw 7 Th Street
Gainesville, FL, 32601
Gainesville, FL, 32601